Immutep's Efti in Combination with MSD's KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck CancerGlobeNewsWire • Monday
Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 ExpressionGlobeNewsWire • 07/11/24
Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical ResultsGlobeNewsWire • 07/03/24
Prima BioMed (IMMP) Loses -34.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 06/28/24
Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for CancerGlobeNewsWire • 06/25/24
Immutep successfully completes institutional placement and institutional component of entitlement offerGlobeNewsWire • 06/05/24
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III TrialGlobeNewsWire • 06/03/24
Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024GlobeNewsWire • 05/15/24
Positive Initial Clinical Data Reported from Immutep's Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue SarcomaGlobeNewsWire • 05/02/24
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort BGlobeNewsWire • 04/24/24
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761GlobeNewsWire • 04/18/24
Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung CancerGlobeNewsWire • 04/17/24
First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial CancerGlobeNewsWire • 01/04/24
Immutep Advances Towards Phase III Trial for Lung Cancer Treatment with Positive Regulatory FeedbackMCAP MediaWire • 12/27/23
Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung CancerGlobeNewsWire • 12/21/23